IEX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
IDEX Corp. is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock shows neutral technical indicators, mixed analyst sentiment, and no significant short-term catalysts. While the company has demonstrated steady financial growth, there are no compelling reasons to enter at the current price level given the lack of strong trading signals or significant positive momentum.
The MACD is positive and expanding, indicating mild bullish momentum. RSI is neutral at 52.071, and moving averages are converging, suggesting no clear trend. The stock is trading near its pivot level of 189.108, with resistance at 193.859 and support at 184.358.
Steady financial growth in Q4 2025, including revenue growth of 4.20%, net income growth of 4.14%, and EPS growth of 5.56%. Analysts have raised price targets recently, with some firms maintaining a Buy rating. The Health and Science Technologies segment shows strong order growth.
No recent congress trading data or insider activity to indicate strong confidence. Hedge funds are neutral, and there are no significant trading trends. Analysts express caution, waiting for sustained organic growth and cyclical improvement. Stock trend analysis predicts a potential short-term decline.
In Q4 2025, IDEX Corp. reported revenue of $899.1M (up 4.20% YoY), net income of $128.3M (up 4.14% YoY), EPS of $1.71 (up 5.56% YoY), and gross margin improvement to 43.05% (up 1.20% YoY).
Analyst sentiment is mixed. While several firms have raised price targets (ranging from $214 to $250) and maintained Buy or Outperform ratings, others remain cautious, citing the need for sustained growth and cyclical improvement before becoming more constructive.
